News > Press Release
Alzheimer's Disease Research
BrightFocus Foundation Statement on the Passing of Peter Davies, PhD
Written By: BrightFocus Editorial Staff
The following statement was issued by Diane Bovenkamp, PhD, BrightFocus Foundation Vice President for Scientific Affairs:
BrightFocus Foundation mourns the recent passing of Peter Davies, PhD. A globally-recognized leader in research on Alzheimer’s and related dementia, Dr. Davies served on our Scientific Review Committee for this field for 11 years, including six years as its chair.
Through this role, Dr. Davies left a lasting legacy of pivotal, early career support for a generation of promising Alzheimer’s researchers, many of whom have gone on to achieve great scientific distinction and impact. He believed strongly in the power of innovation, opening up the Alzheimer’s research field to new and more diverse approaches to ending this disease.
Peter Davies was a scientific pioneer, a generous mentor, and a catalyst for innovation and collaboration. He will be greatly missed.
About BrightFocus Foundation
BrightFocus Foundation is a premier global nonprofit funder of research to defeat Alzheimer’s, macular degeneration, and glaucoma. Through its flagship research programs — Alzheimer’s Disease Research, Macular Degeneration Research, and National Glaucoma Research— the Foundation has awarded nearly $300 million in groundbreaking research funding over the past 51 years and shares the latest research findings, expert information, and resources to empower the millions impacted by these devastating diseases. Learn more at brightfocus.org.
Disclaimer: The information provided here is a public service of BrightFocus Foundation and is not intended to constitute medical advice. Please consult your physician for personalized medical, dietary, and/or exercise advice. Any medications or supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical products or therapies.
News
Related Articles and Information
Press Release
BrightFocus Foundation Receives $3.2 Million Grant for Alzheimer’s Research
BrightFocus Foundation received a $3.2 million grant from an anonymous foundation to support 12 new Alzheimer’s Disease Research grants.
Press Release
Investment in Alzheimer’s Research Today Will Yield Health Benefits for the Next Generation of Adults With Down Syndrome, New Report Finds
Report shows that boosting research investment into the wellbeing of adults with Down syndrome would improve their quality-of-life outcomes, reduce caregiving costs, and extend the lifespan of adults with Down syndrome by five years.
Article
FDA Approves Eli Lilly’s Alzheimer’s Treatment
Another disease-modifying Alzheimer's therapy hits the market.
Article
Upcoming Alzheimer’s Drug Receives Unanimous Support from FDA Advisory Committee
An FDA decision on Eli Lilly's donanemab is expected in the coming months.
